Morgan Stanley’s Tiziana Life Sciences TLSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
73,271
-65,761
| -47% | -$104K | ﹤0.01% | 6076 |
|
|
2025
Q1 | $150K | Buy |
139,032
+28,201
| +25% | +$30.5K | ﹤0.01% | 5847 |
|
|
2024
Q4 | $77.2K | Buy |
110,831
+1,084
| +1% | +$755 | ﹤0.01% | 6149 |
|
|
2024
Q3 | $105K | Sell |
109,747
-769
| -0.7% | -$738 | ﹤0.01% | 5985 |
|
|
2024
Q2 | $102K | Sell |
110,516
-15,622
| -12% | -$14.4K | ﹤0.01% | 5959 |
|
|
2024
Q1 | $57.3K | Sell |
126,138
-122,124
| -49% | -$55.4K | ﹤0.01% | 6161 |
|
|
2023
Q4 | $139K | Buy |
248,262
+120,628
| +95% | +$67.6K | ﹤0.01% | 6063 |
|
|
2023
Q3 | $84.2K | Sell |
127,634
-2,297
| -2% | -$1.52K | ﹤0.01% | 5965 |
|
|
2023
Q2 | $88.5K | Buy |
129,931
+11,806
| +10% | +$8.05K | ﹤0.01% | 6006 |
|
|
2023
Q1 | $129K | Sell |
118,125
-25,434
| -18% | -$27.8K | ﹤0.01% | 5909 |
|
|
2022
Q4 | $85.9K | Sell |
143,559
-38,441
| -21% | -$23K | ﹤0.01% | 6053 |
|
|
2022
Q3 | $142K | Buy |
182,000
+31,083
| +21% | +$24.3K | ﹤0.01% | 5899 |
|
|
2022
Q2 | $112K | Buy |
150,917
+56,057
| +59% | +$41.6K | ﹤0.01% | 6214 |
|
|
2022
Q1 | $100K | Sell |
94,860
-19,848
| -17% | -$20.9K | ﹤0.01% | 6312 |
|
|
2021
Q4 | $110K | Sell |
114,708
-64,753
| -36% | -$62.1K | ﹤0.01% | 6386 |
|
|
2021
Q3 | $262K | Sell |
179,461
-102,156
| -36% | -$149K | ﹤0.01% | 5861 |
|
|
2021
Q2 | $660K | Sell |
281,617
-16,246
| -5% | -$38.1K | ﹤0.01% | 5345 |
|
|
2021
Q1 | $825K | Sell |
297,863
-13,058
| -4% | -$36.2K | ﹤0.01% | 4842 |
|
|
2020
Q4 | $628K | Sell |
310,921
-39,084
| -11% | -$78.9K | ﹤0.01% | 4935 |
|
|
2020
Q3 | $1.17M | Buy |
350,005
+318,775
| +1,021% | +$1.06M | ﹤0.01% | 4097 |
|
|
2020
Q2 | $80K | Buy |
+31,230
| New | +$80K | ﹤0.01% | 5503 |
|